Concentric Analgesics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 20
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 6

Concentric Analgesics General Information

Description

Developer of novel and non-opioid therapeutics designed to provide pain relief after a single local administration. The company's therapeutics target pain at source with limited systematic exposure and reliefs without numbness or weakness during surgery, enabling medical professionals to simplify ongoing care and adherence, improve outcomes and reduce intensity of care for osteoarthritis patients.

Contact Information

Website
www.concentricanalgesics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Pharmaceuticals
Biotechnology
Primary Office
  • 101 California Street
  • Suite 1210
  • San Francisco, CA 94111
  • United States
+1 (415) 000-0000

Concentric Analgesics Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Concentric Analgesics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Debt - PPP 29-Apr-2020 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 21-May-2019 0000 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Dec-2016 $8.36M $8.36M 000.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Concentric Analgesics’s complete valuation and funding history, request access »

Concentric Analgesics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
To view Concentric Analgesics’s complete cap table history, request access »

Concentric Analgesics Executive Team (5)

Name Title Board Seat Contact Info
Frank Bellizzi Jr. Chief Executive Officer & Board Member
John Donovan MD Co-Founder, Chief Scientific Officer, President & Board Member
Ryan Daws Chief Financial Officer
Craig Husfeld Ph.D Co-Founder, Vice President of Medicinal Chemistry & Research & Board Member
You’re viewing 4 of 5 executive team members. Get the full list »

Concentric Analgesics Board Members (4)

Name Representing Role Since
Craig Husfeld Ph.D Concentric Analgesics Co-Founder, Vice President of Medicinal Chemistry & Research & Board Member 000 0000
Frank Bellizzi Jr. Concentric Analgesics Chief Executive Officer & Board Member 000 0000
John Donovan MD Concentric Analgesics Co-Founder, Chief Scientific Officer, President & Board Member 000 0000
Thomas King Concentric Analgesics Executive Chairman 000 0000
To view Concentric Analgesics’s complete board members history, request access »

Concentric Analgesics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Concentric Analgesics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cowen Healthcare Investments Venture Capital Minority 000 0000 000000 0
Gravitas Americas Venture Capital Minority 000 0000 000000 0
Jay Kern Angel (individual) Minority 000 0000 000000 0
Oracle Investment Management Hedge Fund Minority 000 0000 000000 0
Venrock Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial